Biocon Biologics said it has completed the integration of the acquired biosimilars business from Viatris Inc in over 70 countries in emerging markets effective July...
Continue ReadingForaying into the child nutrition segment, drug maker Dr. Reddy’s Laboratories launched CeleHealth Kidz Immuno Plus Gummies in the Indian market on other day. The...
Continue ReadingAurobindo Pharma subsidiary CuraTeQ Biologics has entered into an exclusive license agreement with U.S. firm BioFactura Inc to commercialise BFI-751, a proposed biosimilar to recombinant...
Continue ReadingPharmaceutical company, Dr Reddy’s Laboratories, announced that it is entering into the trade generics business in India with the launch of its new division, ‘RGenX’....
Continue ReadingGranules India Limited, a pharmaceutical company, has completed the U.S. Food and Drug Administration’s (US FDA) Pre-Approval Inspection (PAI) and GMP audit for their Unit...
Continue ReadingAurobindo Pharma Limited (along with its subsidiaries together referred to as “Aurobindo”) announced that the breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin),...
Continue ReadingAurobindo Pharma said its wholly-owned arm, Eugia Pharma Specialities Ltd has entered into a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and...
Continue ReadingSun Pharmaceutical’s subsidiary, Sun Pharma Canada Inc. has received Health Canada’s approval for ABSORICA LD, an oral drug used to treat severe acne in patients...
Continue ReadingNova IVF Fertility, one of the largest chains of infertility treatment clinics in India, has ambitious plans to expand its network to 100 centers within...
Continue Reading